Department of Cardiology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Cardiology, the First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
J Cell Mol Med. 2019 Nov;23(11):7289-7298. doi: 10.1111/jcmm.14575. Epub 2019 Aug 29.
Long non-coding RNAs (lncRNAs) have been indicated for the regulatory roles in cardiovascular diseases. This study determined the expression of lncRNA TNK2 antisense RNA 1 (TNK2-AS1) in oxidized low-density lipoprotein (ox-LDL)-stimulated human aortic smooth muscle cells (HASMCs) and examined the mechanistic role of TNK2-AS1 in the proliferation and migration of HASMCs. Our results demonstrated that ox-LDL promoted HASMC proliferation and migration, and the enhanced proliferation and migration in ox-LDL-treated HASMCs were accompanied by the up-regulation of TNK2-AS1. In vitro functional studies showed that TNK2-AS1 knockdown suppressed cell proliferation and migration of ox-LDL-stimulated HASMCs, while TNK2-AS1 overexpression enhanced HASMC proliferation and migration. Additionally, TNK2-AS1 inversely regulated miR-150-5p expression via acting as a competing endogenous RNA (ceRNA), and the enhanced effects of TNK2-AS1 overexpression on HASMC proliferation and migration were attenuated by miR-150-5p overexpression. Moreover, miR-150-5p could target the 3' untranslated regions of vascular endothelial growth factor A (VEGFA) and fibroblast growth factor 1 (FGF1) to regulate FGF1 and VEGFA expression in HASMCs, and the inhibitory effects of miR-150-5p overexpression in ox-LDL-stimulated HASMCs were attenuated by enforced expression of VEGFA and FGF1. Enforced expression of VEGFA and FGF1 also partially restored the suppressed cell proliferation and migration induced by TNK2-AS1 knockdown in ox-LDL-stimulated HASMCs, while the enhanced effects of TNK2-AS1 overexpression on HASMC proliferation and migration were attenuated by the knockdown of VEGFA and FGF1. Collectively, our findings showed that TNK2-AS1 exerted its action in ox-LDL-stimulated HASMCs via regulating VEGFA and FGF1 expression by acting as a ceRNA for miR-150-5p.
长链非编码 RNA(lncRNA)在心血管疾病的调控中具有重要作用。本研究旨在探讨 lncRNA TNK2 反义 RNA 1(TNK2-AS1)在氧化型低密度脂蛋白(ox-LDL)刺激的人主动脉平滑肌细胞(HASMCs)中的表达,并研究 TNK2-AS1 在 HASMCs 增殖和迁移中的作用机制。结果表明,ox-LDL 促进 HASMC 的增殖和迁移,ox-LDL 处理的 HASMC 中 TNK2-AS1 的上调伴随着增殖和迁移的增强。体外功能研究表明,TNK2-AS1 敲低抑制 ox-LDL 刺激的 HASMC 增殖和迁移,而过表达 TNK2-AS1 则增强 HASMC 的增殖和迁移。此外,TNK2-AS1 通过作为竞争性内源性 RNA(ceRNA)反式调控 miR-150-5p 的表达,而 miR-150-5p 过表达减弱了 TNK2-AS1 过表达对 HASMC 增殖和迁移的增强作用。此外,miR-150-5p 可以靶向血管内皮生长因子 A(VEGFA)和成纤维细胞生长因子 1(FGF1)的 3'UTR 来调节 HASMC 中 FGF1 和 VEGFA 的表达,而 miR-150-5p 过表达对 ox-LDL 刺激的 HASMCs 的抑制作用被 VEGFA 和 FGF1 的强制表达所减弱。VEGFA 和 FGF1 的强制表达也部分恢复了 TNK2-AS1 敲低对 ox-LDL 刺激的 HASMCs 中增殖和迁移的抑制作用,而过表达 TNK2-AS1 对 HASMC 增殖和迁移的增强作用则被 VEGFA 和 FGF1 的敲低所减弱。综上所述,我们的研究结果表明,TNK2-AS1 通过作为 miR-150-5p 的 ceRNA 调节 VEGFA 和 FGF1 的表达,从而在 ox-LDL 刺激的 HASMCs 中发挥作用。